Genesis Molecular AI vs Numerion Labs (2026)
Both develop small molecules on AI platforms built around structure. Genesis Molecular AI runs GEMS, with generative models for ideation, multitask models for drug properties and agents for routine steps, and its Pearl model, released in October 2025, predicts protein ligand structures and can be fine tuned on a program's own data. It publishes measured results against named baselines. Numerion Labs, formerly Atomwise, works in immune and inflammatory disease on COSMOS, APEX and EXPO, and its Atomwise era AIMS study found novel hits for 235 of 318 academic targets. Both work mainly through their own programs and partnerships rather than software sales.
- Pearl, a protein ligand structure model trained on proprietary physics based synthetic data and fine tunable on a program's data.
- Measured results with denominators against named baselines.
- Agents that orchestrate routine work while chemists keep the decisions.
- A prospective published screening record: novel hits for 235 of 318 academic targets in the AIMS study (Scientific Reports, 2024).
- A current platform of COSMOS, APEX and EXPO, aimed at immune and inflammatory disease.
- Enumeration at scale, described in October 2025 research with NVIDIA.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Genesis Molecular AI and Numerion Labs are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Genesis Molecular AI | Numerion Labs |
|---|---|---|
| Primary category | Drug Discovery AI | Drug Discovery AI |
| Founded | 2019 | Not recorded |
| Headquarters | Burlingame, CA | San Francisco, CA |
| Website | genesis.ml | numerionlabs.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Genesis Molecular AI its top capability grade on AI Centrality. Set against Numerion Labs, Genesis Molecular AI grades higher on Model Supply Chain Disclosure. Its thinnest published disclosure sits on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
The AI Health Index awards Numerion Labs its top capability grade on AI Centrality. Set against Genesis Molecular AI, Numerion Labs grades higher on AI Safety and PHI Stewardship, HIPAA and BAA Posture and Setting and Specialty Coverage. Its thinnest published disclosure sits on Security Certifications and Trust Center and EHR and Interoperability Depth. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
Questions buyers ask
Should we choose Genesis Molecular AI or Numerion Labs?
On the axes where the AI Health Index separates them, Genesis Molecular AI grades higher on Model Supply Chain Disclosure, and Numerion Labs grades higher on AI Safety and PHI Stewardship, HIPAA and BAA Posture and Setting and Specialty Coverage. Numerion Labs leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Genesis Molecular AI and Numerion Labs differ most?
The widest separation the AI Health Index records between Genesis Molecular AI and Numerion Labs is on HIPAA and BAA Posture, where Genesis Molecular AI grades D and Numerion Labs grades B. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Genesis Molecular AI and Numerion Labs grade the same?
The AI Health Index grades Genesis Molecular AI and Numerion Labs the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Genesis Molecular AI and Numerion Labs not disclosed?
At the last review, at least one of Genesis Molecular AI and Numerion Labs published thin or absent detail on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and Security Certifications and Trust Center. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Drug Discovery AI page.
Both records were reviewed on this site in September 2026. Neither publishes prices, and Numerion's strongest published result predates its rename.
Ask both which published results came from the platform version you would use.